Effect of ascorbic acid on inflammatory markers after cardiothoracic surgery

American Journal of Health-System Pharmacy

Volumn 68, Issue 17, 2011, Pages 1632-1639

  Colby, Jennifer A ^a   Chen, Wendy T ^a   Baker, William L ^b,c   Coleman, Craig I ^d,e   Reinhart, Kurt ^f   Kluger, Jeffrey ^g   White, C Michael ^d,e  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d UC   (United States)

^e UC/HH Evidence Based Practice Center   (United States)

^f WINGATE UNIVERSITY   (United States)

^g Arrhythmia Services   (United States)

Author keywords

Antioxidants; Ascorbic acid; Cardiopulmonary bypass; Cardiovascular surgical procedures; Inflammation

Indexed keywords

ASCORBIC ACID; C REACTIVE PROTEIN; FIBRINOGEN; PLACEBO;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS GRAFT SURGERY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART VALVE REPLACEMENT; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THORAX SURGERY;

EID: 80052704013     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100703     Document Type: Article

References (29)

1. Fuster V, Rydén LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol. 2006; 48:e149-246. (Pubitemid 44175744)
2. Mathew JP, Fontes ML, Tudor IC et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004; 291:1720-9. (Pubitemid 38489894)
3. Hague CW, Creswell LL, Gutterman DD et al. Epidemiology, mechanisms, and risks: American College of ChestPhysicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 2005; 128(suppl):9s-16s. (Pubitemid 41134235)
4. Jongnarangsin K, Oral H. Postoperative atrial fibrillation. Cardiol Clin. 2009; 27:69-78.
5. Baker WL, White CM. Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies. Ann Pharmacother. 2007; 41:587-98. (Pubitemid 46628626)
6. Gaudino M, Andreotti F, Zamparelli R et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation. 2003; 108(suppl 1):II195-9. (Pubitemid 37099954)
7. Boyle EM Jr, Pohlman TH, Johnson MC et al. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg. 1997; 64(suppl 4):S31-7.
8. Bruins P, te Velthuis H, Yazdanbakhsh AP et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997; 96:3542-8. (Pubitemid 27513431)
9. Abdelhadi RH, Gurm HS, Van Wagoner DR et al. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol. 2004; 93:1176-8. (Pubitemid 38521055)
10. Lamm G, Auer J, Weber T et al. Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth. 2006; 20:51-6. (Pubitemid 43182777)
11. Carnes CA, Chung MK, Nakayama T et al. Ascorbate attenuated atrial pacinginduced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res. 2001; 89:e32-8.
12. Eslami M, Badkoubeh RS, Mousavi M et al. Oral ascorbic acid in combination with beta-blockers. Tex Heart Inst J. 2007; 34:268-74.
13. Moher D, Hopewell S, Schulz KF et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c869.
14. Plenge JK, Hernandez TL, Weil KM et al. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation. 2002; 106:1447-52.
15. Giri S, White CM, Dunn AB et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Suppression Trial (AFIST): a randomised placebo-controlled trial. Lancet. 2001; 357:830-6. (Pubitemid 32239367)
16. White CM, Caron MF, Kalus JS et al. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation. 2003; 108(suppl):II200-6. (Pubitemid 37099955)
17. Rodrigo R, Vinay J, Castillo R et al. Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillation. Int J Cardiol. 2010; 138:221-8.
18. Patti G, Chello M, Candura D et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006; 114:1455-61. (Pubitemid 44526999)
19. Cheruku KK, Ghani A, Ahmad F et al. Efficacy of nonsteroidal anti-inflammatory medications for prevention of atrial fibrillation following coronary artery bypass graft surgery. Prev Cardiol. 2004; 7:13-8.
20. Prasongsukarn K, Abel JG, Jamieson WR et al. The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial. J Thorac Cardiovasc Surg. 2005; 130:93-8. (Pubitemid 40941674)
21. Marín F, Pascual DA, Roldán V et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol. 2006; 97:55-60. (Pubitemid 41828123)
22. Ray KK, Cannon CP, Morrow DA et al. Prognostic utility of ApoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE-IT-TIMI 22. Arterioscler Thromb Vasc Biol. 2009; 29:424-30.
23. Song SW, Yi G, Lee S et al. Perioperative indicators of stress response and postoperative inflammatory complications in patients undergoing off-pump coronary artery bypass surgery: a prospective observational study. Circ J. 2008; 72:1966- 74.
24. Parolari A, Camera M, Sci B et al. Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up. Ann Thorac Surg. 2007; 84:823-8. (Pubitemid 47285029)
25. Paulitsch FS, Schneider D, Sobel BE et al. Hemostatic changes and clinical sequelaeafter on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized study. Coron Artery Dis. 2009; 20:100-5.
26. Korantzopoulos P, Kolettis TM, Kountouris E et al. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol. 2005; 102:321-6. (Pubitemid 40854050)
27. Rimmelé T, Venkataraman R, Madden NJ et al. Comparison of inflammatory response during on-pump and off-pump coronary artery bypass surgery. Int J Artif Organs. 2010; 33:131-8.
28. Quaniers JM, Leruth J, Albert A et al. Comparison of inflammatory responses after off-pump and on-pump coronary surgery using surface modifying additives circuit. Ann Thorac Surg. 2006; 81:1683-90. (Pubitemid 350030008)
29. Castellheim A, Hoel TN, Videm V et al. Biomarker profile in off-pump and onpump coronary artery bypass grafting surgery in low-risk patients. Ann Thorac Surg. 2008; 85:1994-2002. (Pubitemid 351695495)